INFLAMMATORY MARKERS AND SYMPTOM BURDEN IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

被引：0
|
作者：
Williams, Loretta [1 ]
Wang, Xin Shelley [1 ]
Shi, Quiling [1 ]
Reuben, James M. [1 ]
Shah, Nina [1 ]
Johnson, Valen E. [2 ]
Cleeland, Charles S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Texas A&M Univ, College Stn, TX USA
来源：
ONCOLOGY NURSING FORUM | 2013年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E457 / E457
页数：1
相关论文
共 50 条
  • [41] Impact of Diabetes Mellitus on Outcomes of Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma in the US
    Siwakoti, Krishmita
    Giri, Smith
    Bhatt, Vijay
    DIABETES, 2018, 67
  • [42] Impact of infused lymphocyte dose on the outcome of patients with multiple myeloma undergoing autologous stem cell transplantation
    Symeonidis, A.
    Ings, S.
    Rabin, N.
    Watts, M.
    D'Sa, S.
    Linch, D.
    Yong, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 188 - 189
  • [43] Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation
    Vaxman, Iuliana
    Visram, Alissa
    Kapoor, Prashant
    Kumar, Shaji
    Dispenzieri, Angela
    Buadi, Francis
    Dingli, David
    Muchtar, Eli
    Gonsalves, Wilson
    Rajkumar, Vincent
    Kourelis, Taxiarchis
    Warsame, Rahma
    Lacy, Martha
    Gertz, Morie A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : E35 - E38
  • [44] The effect of melphalan administration time on engraftment in multiple myeloma patients undergoing autologous stem cell transplantation
    Unal, Ali
    Yildizhan, Esra
    Kaynar, Leylagul
    Varal, Fatma
    Ciftci, Sibel
    Coskun, Elmas
    Yildiz, Gulseren
    Yanar, Ayse
    Eser, Bulent
    Cetin, Mustafa
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 293
  • [45] A Response Adapted Approach to Induction Treatment in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Shah, Gunjan L.
    Weltz, Jonathan
    Zhou, Quin
    Devlin, Sean M.
    Landau, Heather
    Chung, David J.
    Lendvai, Nikoletta
    Lesokhin, Alexander M.
    Korde, Neha
    Koehne, Guenther
    Giralt, Sergio A.
    Hassoun, Hani
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S40 - S41
  • [46] Intravenous neridronate for treatment of skeletal involvement in patients undergoing autologous stem cell transplantation for multiple myeloma
    Pittari, G
    Costi, D
    Mangoni, L
    Frigelli, S
    Baroni, MC
    Rizzoli, V
    BONE MARROW TRANSPLANTATION, 2004, 33 : S162 - S162
  • [47] Colitis in multiple myeloma patients undergoing chemotherapy and autologous stem cell transplantation: Incidence, and risk factors
    Krishna, Somashekar
    Weizhi, Zhao
    Chepyala, Pavan
    Grazziutti, Monica
    Miceli, Marisa
    Jalil, Basma A.
    Olden, Kevin W.
    Barlogie, Bart
    Anaissie, Elias
    GASTROENTEROLOGY, 2007, 132 (04) : A670 - A670
  • [48] Iron balance in multiple myeloma patients undergoing autologous stem cell transplantation: hepcidin and ferritin assessment
    Piccirillo, N.
    Ausoni, G.
    Chiusolo, P.
    Laurenti, L.
    Sora, F.
    Giammarco, S.
    Rossi, E.
    Za, T.
    Zini, G.
    De Stefano, V.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S507 - S508
  • [49] Bisphosphonate Induced Osteonecrosis of the Jaw (BONJ) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Oduncu, Fuat
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E77 - E78
  • [50] Individualized high dose busulfan in patients undergoing autologous stem cell transplantation for multiple myeloma.
    Clopés, A
    Sureda, A
    Brunet, S
    Altés, A
    Martino, R
    Paladio, N
    Queraltó, JM
    Mangues, MA
    Sierra, J
    BLOOD, 2001, 98 (11) : 201A - 201A
12345